glp 1 vs 3 GLP-1 Receptor Agonists as Treatments for Type 2 Diabetes 3 Takeaways from the Landmark
Description
Tirzepatide was also associated with a significantly lower risk of all-cause mortality compared with dulaglutide [7]
[DOI] [PubMed] [Google Scholar] 11.Herrmann C, Gke R, Richter G, Fehmann HC, Arnold R, Gke B
Thus, the pooled and meta-analysis data suggest that GLP-1RA has a small, favorable effect on systolic BP in patients with T2DM
Smaller Novartis Post-Sandoz Grows Core Business Novartiss slippage on the league table in 2024 reflects the spin-out of its Sandoz generics and biosimilars business in October 2023
